Genetic Parameters of Fertility Disorders and Mastitis in the Swedish Friesian Breed

Abstract

Genetic parameters of fertility disorders and mastitis in the Swedish Friesian breed (SLB) were estimated from 9516 observations, using a restricted multiple trait maximum likelihood method. Information on individual cow diagnosis for fertility disorders and mastitis was obtained from registered veterinary treatments matched with AI data and data from the milk-recording scheme, including culling reasons. Heritability estimates for fertility disorders and mastitis using only veterinary treatments as sources of information were 0.008±0.011 and 0.018±0.015, respectively. Including culling reasons gave a significant increase in heritability estimate for mastitis (0.083±0.030), but not for fertility disorders (0.001±0.003). Increased incidence of fertility disorders and decreased incidence of mastitis were found for SLB cows with a high proportion of imported Holstein Friesian genes. Estimates of heterosis effects were small and not significant. Estimated recombination effects were negative for fertility disorders and positive for mastitis.     

The influence of fencing on seedling establishment during reforestation of oak stands: a comparison of artificial and natural regeneration techniques including costs

European Journal of Forest Research - In temperate Europe, oak-dominated forests are widespread, supporting high biodiversity and providing important ecosystem services. Insufficient natural...     

Quantification of the bioactive compound eritadenine in selected strains of shiitake mushroom (Lentinus edodes)

Cardiovascular disease is one of the most common causes of death in the Western world, and a high level of blood cholesterol is considered a risk factor. The edible fungus, shiitake mushroom (Lentinus edodes), contains the hypocholesterolemic agent eritadenine, 2(R),3(R)-dihydroxy-4-(9-adenyl)-butyric acid. This study was conducted to quantify the amount of the cholesterol reducing agent eritadenine in shiitake mushrooms, in search of a potential natural medicine against blood cholesterol. The amounts of eritadenine in the fruit bodies of four different shiitake mushrooms, Le-1, Le-2, Le-A, and Le-B, were investigated in this study. To achieve this goal, methanol extraction was used to recover as much as possible of the hypocholesterolemic agent from the fungal cells. In addition, enzymes that degrade the fungal cell walls were also used to elucidate if the extraction could be further enhanced. To analyze the target compound, a reliable and reproducible HPLC method for separation, identification, and quantification of eritadenine was developed. The shiitake strains under investigation exhibit up to 10 times higher levels of eritadenine than previously reported for other shiitake strains. Further, pretreating the mushrooms with hydrolytic enzymes before methanol extraction resulted in an insignificant increase in the amount of eritadenine released. These results indicate the potential for delivery of therapeutic amounts of eritadenine from the ingestion of extracts or dried concentrates of shiitake mushroom strains.     

Detection of the origin of atrial tachycardia by 3D electro‐anatomical mapping and treatment by radiofrequency catheter ablation in horses

BackgroundAtrial tachycardia (AT) can be treated by medical or electrical cardioversion but the recurrence rate is high. Three‐dimensional electro‐anatomical mapping, recently described in horses, might be used to map AT to identify a focal source or reentry mechanism and to guide treatment by radiofrequency ablation.ObjectivesTo describe the feasibility of 3D electro‐anatomical mapping and radiofrequency catheter ablation to characterize and treat sustained AT in horses.AnimalsNine horses with sustained AT.MethodsRecords from horses with sustained AT referred for radiofrequency ablation at Ghent University were reviewed.ResultsThe AT was drug resistant in 4 out of 9 horses. In 8 out of 9 horses, AT originated from a localized macro‐reentrant circuit (n = 5) or a focal source (n = 3) located at the transition between the right atrium and the caudal vena cava. In these 8 horses, local radiofrequency catheter ablation resulted in the termination of AT. At follow‐up, 6 out of 8 horses remained free of recurrence.Conclusions and Clinical ImportanceDifferentiation between focal and macro‐reentrant AT in horses is possible using 3D electro‐anatomical mapping. In this study, the source of right atrial AT in horses was safely treated by radiofrequency catheter ablation.